Tech Surges on Cerebras Euphoria -- Tech Roundup

Dow Jones05-15

Shares of technology companies rose as an initial public offering stoked artificial-intelligence euphoria further.

Shares of AI chip maker Cerebras soared in their stock-market debut, more than doubling at one point, after pricing its IPO well above expectations. The Cerebras IPO was widely viewed as a trial run for even larger flotations of AI leaders SpaceX, OpenAI and Anthropic, all planned for later this year.

Nvidia, the leading maker of sophisticated AI-supporting chips, rose in sympathy, continuing a torrid run that has brought the AI bellwether to the cusp of a $6 trillion valuation. Other corners of the red-hot semiconductor sub-sector cooled down, however.

SMIC, China's biggest chip foundry, reported weaker-than-expected net profit at the start of the year as it continued expanding capacity amid Beijing's push for chip localization.

Shares of Intel and memory-chip makers such as Micron and Sandisk, lost ground.

Cisco Systems shares surged, rising by more than 13% for their biggest gain in 15 years as the network-equipment maker's earnings were buoyed by AI products.

Attorneys for Elon Musk and OpenAI began making final statements Thursday, closing out the third week of a blockbuster trial litigating the past, and likely the future, of the AI boom.

 

Write to Rob Curran at rob.curran@dowjones.com

(END) Dow Jones Newswires

May 14, 2026 18:01 ET (22:01 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment